Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?

Detalles Bibliográficos
Autores principales: Kobashi, Yurie, Watanabe, Makoto, Kimura, Hideaki, Higuchi, Asaka, Ozaki, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2019
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819628/
https://www.ncbi.nlm.nih.gov/pubmed/31657193
http://dx.doi.org/10.15171/ijhpm.2019.60
_version_ 1783463778466136064
author Kobashi, Yurie
Watanabe, Makoto
Kimura, Hideaki
Higuchi, Asaka
Ozaki, Akihiko
author_facet Kobashi, Yurie
Watanabe, Makoto
Kimura, Hideaki
Higuchi, Asaka
Ozaki, Akihiko
author_sort Kobashi, Yurie
collection PubMed
description
format Online
Article
Text
id pubmed-6819628
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-68196282019-11-04 Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians? Kobashi, Yurie Watanabe, Makoto Kimura, Hideaki Higuchi, Asaka Ozaki, Akihiko Int J Health Policy Manag Letter to Editor Kerman University of Medical Sciences 2019-07-24 /pmc/articles/PMC6819628/ /pubmed/31657193 http://dx.doi.org/10.15171/ijhpm.2019.60 Text en © 2019 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Kobashi, Yurie
Watanabe, Makoto
Kimura, Hideaki
Higuchi, Asaka
Ozaki, Akihiko
Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
title Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
title_full Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
title_fullStr Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
title_full_unstemmed Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
title_short Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
title_sort are pharmaceutical company payments incentivising malpractice in japanese physicians?
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819628/
https://www.ncbi.nlm.nih.gov/pubmed/31657193
http://dx.doi.org/10.15171/ijhpm.2019.60
work_keys_str_mv AT kobashiyurie arepharmaceuticalcompanypaymentsincentivisingmalpracticeinjapanesephysicians
AT watanabemakoto arepharmaceuticalcompanypaymentsincentivisingmalpracticeinjapanesephysicians
AT kimurahideaki arepharmaceuticalcompanypaymentsincentivisingmalpracticeinjapanesephysicians
AT higuchiasaka arepharmaceuticalcompanypaymentsincentivisingmalpracticeinjapanesephysicians
AT ozakiakihiko arepharmaceuticalcompanypaymentsincentivisingmalpracticeinjapanesephysicians

Ejemplares similares